Jacqueline To, MD
Internal Medicine · Los Altos
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 9 years
- Graduated 2017
On the public record
- Has dropped Medicare — you would pay privately
Offices
1 location
Looking this up.
Hospitals listed: 757662 · El Camino Health · Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. To’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A160368 · Current
Licensed to practise in California · since 2019 · expires 2027-01-31 · University of Colorado School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$93,436
Medicare paid this office $93,436 for 235 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 107 | $33,434 | $172 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 159 | $25,082 | $158 |
| Return visit (30+ min) | 141 | $20,279 | $117 |
| Short return visit (20+ min) | 43 | $3,400 | $77 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 11 | $3,213 | $292 |
See all 11 services
| Long return visit (40+ min) | 107 | $33,434 | $172 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 159 | $25,082 | $158 |
| Return visit (30+ min) | 141 | $20,279 | $117 |
| Short return visit (20+ min) | 43 | $3,400 | $77 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 11 | $3,213 | $292 |
| Sarscov2 vac 50 mcg/0.5ml im | 12 | $1,809 | $151 |
| Influenza vaccine, inactivated | 16 | $1,309 | $82 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 19 | $1,216 | $51 |
| Admn sarscov2 vacc 1 dose | 12 | $625 | $52 |
| Administration of influenza virus vaccine | 16 | $625 | $39 |
| Administration of pneumococcal vaccine | 11 | $399 | $36 |
Who their Medicare patients are
235 Original Medicare patients in 2024. Average age 77 · Women 65% · Health risk score 0.82. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 57% · Coronary heart disease 20% · Depression 15% · Chronic kidney disease 14% · Cancer 14% · Atrial fibrillation 14% · Diabetes 12% · Heart failure 8% · Stroke 6% · COPD 5%.
The office billed $229,277, Medicare allowed $110,926 and paid $93,436; for 712 services of 18 kinds; $6,475 of it was for drugs given in the office and $86,960 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 235 | 712 | 77 | 0.82 | $229,277 | $93,436 |
| 2023 | 281 | 826 | 78 | 0.85 | $246,848 | $95,685 |
| 2022 | 332 | 1,032 | 77 | 0.76 | $285,689 | $119,065 |
| 2021 | 296 | 772 | 77 | 0.77 | $213,331 | $91,217 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Long return visit (40+ min) | 91 | $30,320 | $158 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 159 | $24,788 | $156 |
| Return visit (30+ min) | 147 | $22,012 | $107 |
| Short return visit (20+ min) | 92 | $7,046 | $66 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 22 | $1,662 | $76 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 23 | $1,584 | $47 |
| Administration of influenza virus vaccine | 24 | $887 | $37 |
| Administration of pneumococcal vaccine | 11 | $377 | $34 |
2022: 9 services
| Long return visit (40+ min) | 119 | $32,412 | $161 |
| Return visit (30+ min) | 194 | $30,672 | $109 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 194 | $30,236 | $156 |
| Short return visit (20+ min) | 107 | $9,076 | $74 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 40 | $2,810 | $70 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $2,770 | $111 |
| Administration of influenza virus vaccine | 40 | $1,489 | $37 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 23 | $1,291 | $48 |
| Administration of pneumococcal vaccine | 12 | $404 | $34 |
2021: 9 services
| Long return visit (40+ min) | 162 | $39,494 | $167 |
| Return visit (30+ min) | 130 | $17,657 | $118 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 119 | $17,136 | $144 |
| Short return visit (20+ min) | 63 | $5,580 | $85 |
| Influenza vaccine split virus, preservative free | 53 | $3,459 | $65 |
| Pneumococcal vaccine, 23-valent | 14 | $1,763 | $126 |
| Administration of influenza virus vaccine | 53 | $1,145 | $22 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 13 | $942 | $52 |
| Administration of pneumococcal vaccine | 15 | $326 | $22 |
Drugs they prescribed that Part D paid
$162,959
Pharmacies billed $162,959 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (25 of 3,132) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
2,840 generic and fewer than 11 brand-name prescriptions · $162,959 in drug cost · 29 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 29 | $27,080 | $934 |
| Xarelto | 17 | $18,793 | $1,105 |
| Myrbetriq | 13 | $12,808 | $985 |
| Trelegy Ellipta | 12 | $7,615 | $635 |
| Premarin | 12 | $5,178 | $431 |
See all 65 drugs
| Eliquis | 29 | $27,080 | $934 |
| Xarelto | 17 | $18,793 | $1,105 |
| Myrbetriq | 13 | $12,808 | $985 |
| Trelegy Ellipta | 12 | $7,615 | $635 |
| Premarin | 12 | $5,178 | $431 |
| Atorvastatin | 377 | $3,247 | $9 |
| Synthroid | 32 | $1,912 | $60 |
| Gabapentin | 81 | $1,831 | $23 |
| Amlodipine Besylate | 282 | $1,830 | $6 |
| Losartan | 200 | $1,820 | $9 |
| Valsartan | 62 | $1,765 | $28 |
| Levothyroxine | 175 | $1,696 | $10 |
| Valacyclovir | 13 | $1,358 | $104 |
| Rosuvastatin | 74 | $1,134 | $15 |
| Pregabalin | 24 | $954 | $40 |
| Midodrine | 15 | $931 | $62 |
| Lisinopril | 127 | $859 | $7 |
| Mirtazapine | 14 | $831 | $59 |
| Estradiol | 14 | $781 | $56 |
| Escitalopram | 34 | $714 | $21 |
| Metoprolol | 40 | $688 | $17 |
| Felodipine Er | 12 | $656 | $55 |
| Bupropion Xl | 18 | $643 | $36 |
| Pantoprazole | 28 | $587 | $21 |
| Propranolol | 13 | $551 | $42 |
| Fluticasone Propionate | 13 | $551 | $42 |
| Irbesartan | 34 | $549 | $16 |
| Duloxetine | 12 | $508 | $42 |
| Simvastatin | 61 | $485 | $8 |
| Alendronate | 57 | $463 | $8 |
| Tamsulosin | 29 | $460 | $16 |
| Potassium Chloride | 26 | $408 | $16 |
| Allopurinol | 28 | $384 | $14 |
| Hydrocodone-Acetaminophen | 16 | $357 | $22 |
| Celecoxib | 14 | $348 | $25 |
| Hydrochlorothiazide | 68 | $341 | $5 |
| Trazodone | 31 | $341 | $11 |
| Finasteride | 29 | $337 | $12 |
| Citalopram Hbr | 29 | $333 | $11 |
| Venlafaxine Hcl Er | 24 | $332 | $14 |
| Pravastatin | 23 | $316 | $14 |
| Albuterol Sulfate Hfa | 16 | $311 | $19 |
| Fluoxetine | 18 | $289 | $16 |
| Montelukast | 25 | $274 | $11 |
| Warfarin | 15 | $255 | $17 |
| Metformin | 56 | $241 | $4 |
| Omeprazole | 32 | $218 | $7 |
| Ketoconazole | 11 | $213 | $19 |
| Bupropion | 11 | $212 | $19 |
| Paroxetine | 12 | $211 | $18 |
| Buspirone | 22 | $195 | $9 |
| Famotidine | 20 | $192 | $10 |
| Furosemide | 27 | $187 | $7 |
| Triamterene-Hydrochlorothiazid | 13 | $170 | $13 |
| Hydralazine | 12 | $167 | $14 |
| Sumatriptan | 16 | $161 | $10 |
| Lovastatin | 15 | $133 | $9 |
| Olmesartan Medoxomil | 11 | $131 | $12 |
| Zolpidem | 24 | $117 | $5 |
| Alprazolam | 12 | $116 | $10 |
| Metformin Hcl Er | 17 | $114 | $7 |
| Metoprolol | 12 | $103 | $9 |
| Clonazepam | 13 | $96 | $7 |
| Benazepril | 12 | $52 | $4 |
| Carvedilol | 13 | $44 | $3 |
Year by year
| 2024 | 3,132 | 299 | 1% (25) | None | $162,959 |
| 2023 | 3,333 | 319 | 1% (31) | 9% | $209,977 |
| 2022 | 2,908 | 313 | 1% (39) | None | $141,582 |
| 2021 | 1,095 | 233 | 3% (29) | 10% | $50,587 |
| 2018 | 15 | None | 0% (0) | 0% | $367 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 68 drugs
| Xarelto | 17 | $14,389 | $846 |
| Myrbetriq | 21 | $12,251 | $583 |
| Trulicity | 11 | $10,756 | $978 |
| Trelegy Ellipta | 12 | $8,291 | $691 |
| Premarin | 12 | $5,808 | $484 |
| Flovent Hfa | 14 | $4,818 | $344 |
| Atorvastatin | 352 | $3,995 | $11 |
| Losartan | 196 | $2,785 | $14 |
| Amlodipine Besylate | 309 | $2,644 | $9 |
| Valsartan | 74 | $2,604 | $35 |
| Pregabalin | 31 | $2,575 | $83 |
| Estradiol | 23 | $2,344 | $102 |
| Levothyroxine | 147 | $2,306 | $16 |
| Gabapentin | 76 | $1,662 | $22 |
| Mirtazapine | 27 | $1,642 | $61 |
| Irbesartan | 37 | $1,496 | $40 |
| Rosuvastatin | 81 | $1,495 | $18 |
| Celecoxib | 24 | $1,421 | $59 |
| Estradiol (Twice Weekly) | 14 | $1,413 | $101 |
| Lisinopril | 115 | $1,309 | $11 |
| Valacyclovir | 23 | $1,199 | $52 |
| Synthroid | 17 | $1,164 | $68 |
| Metoprolol | 39 | $835 | $21 |
| Simvastatin | 73 | $812 | $11 |
| Alendronate | 65 | $777 | $12 |
| Venlafaxine Hcl Er | 27 | $700 | $26 |
| Valsartan-Hydrochlorothiazide | 11 | $687 | $62 |
| Fluticasone Propionate | 18 | $661 | $37 |
| Escitalopram | 32 | $630 | $20 |
| Hydrochlorothiazide | 97 | $608 | $6 |
| Metformin | 53 | $594 | $11 |
| Omeprazole | 37 | $592 | $16 |
| Trazodone | 23 | $558 | $24 |
| Potassium Chloride | 23 | $538 | $23 |
| Diltiazem 24hr Er | 11 | $527 | $48 |
| Montelukast | 29 | $519 | $18 |
| Tamsulosin | 28 | $504 | $18 |
| Ketoconazole | 18 | $473 | $26 |
| Citalopram Hbr | 25 | $465 | $19 |
| Bupropion Xl | 18 | $454 | $25 |
| Pantoprazole | 16 | $451 | $28 |
| Allopurinol | 22 | $408 | $19 |
| Lovastatin | 24 | $379 | $16 |
| Triamterene-Hydrochlorothiazid | 22 | $344 | $16 |
| Famotidine | 27 | $343 | $13 |
| Metoprolol | 17 | $327 | $19 |
| Furosemide | 36 | $326 | $9 |
| Sumatriptan | 24 | $310 | $13 |
| Sertraline | 26 | $304 | $12 |
| Hydrocodone-Acetaminophen | 16 | $297 | $19 |
| Pravastatin | 16 | $284 | $18 |
| Bupropion | 12 | $256 | $21 |
| Glipizide | 11 | $230 | $21 |
| Metformin Hcl Er | 22 | $223 | $10 |
| Buspirone | 17 | $218 | $13 |
| Fluoxetine | 19 | $207 | $11 |
| Alprazolam | 16 | $177 | $11 |
| Meloxicam | 29 | $162 | $6 |
| Clonazepam | 17 | $132 | $8 |
| Diclofenac | 12 | $120 | $10 |
| Lorazepam | 22 | $110 | $5 |
| Finasteride | 12 | $100 | $8 |
| Zolpidem | 26 | $98 | $4 |
| Warfarin | 16 | $94 | $6 |
| Carvedilol | 13 | $93 | $7 |
| Lisinopril-Hydrochlorothiazide | 12 | $88 | $7 |
| Benazepril | 14 | $67 | $5 |
| Paroxetine | 12 | $43 | $4 |
2022: 63 drugs
| Eliquis | 14 | $19,300 | $1,379 |
| Trelegy Ellipta | 15 | $9,932 | $662 |
| Myrbetriq | 13 | $6,953 | $535 |
| Premarin | 12 | $5,892 | $491 |
| Atorvastatin | 313 | $3,329 | $11 |
| Valacyclovir | 19 | $2,849 | $150 |
| Losartan | 178 | $2,148 | $12 |
| Levothyroxine | 123 | $2,140 | $17 |
| Irbesartan | 44 | $2,112 | $48 |
| Amlodipine Besylate | 272 | $2,077 | $8 |
| Valsartan | 53 | $2,002 | $38 |
| Estradiol | 19 | $1,935 | $102 |
| Synthroid | 19 | $1,625 | $86 |
| Pregabalin | 26 | $1,624 | $62 |
| Gabapentin | 83 | $1,591 | $19 |
| Celecoxib | 28 | $1,366 | $49 |
| Carbidopa-Levodopa | 14 | $1,239 | $88 |
| Rosuvastatin | 44 | $1,200 | $27 |
| Venlafaxine Hcl Er | 23 | $788 | $34 |
| Escitalopram | 26 | $756 | $29 |
| Bupropion Xl | 15 | $695 | $46 |
| Hydrochlorothiazide | 92 | $677 | $7 |
| Metoprolol | 26 | $653 | $25 |
| Pantoprazole | 24 | $647 | $27 |
| Albuterol Sulfate Hfa | 15 | $636 | $42 |
| Montelukast | 27 | $635 | $24 |
| Potassium Chloride | 28 | $617 | $22 |
| Famotidine | 32 | $547 | $17 |
| Simvastatin | 65 | $546 | $8 |
| Mirtazapine | 18 | $538 | $30 |
| Metformin | 54 | $497 | $9 |
| Warfarin | 19 | $487 | $26 |
| Alendronate | 50 | $455 | $9 |
| Lisinopril | 91 | $452 | $5 |
| Losartan-Hydrochlorothiazide | 12 | $410 | $34 |
| Omeprazole | 28 | $399 | $14 |
| Triamterene-Hydrochlorothiazid | 25 | $387 | $15 |
| Allopurinol | 17 | $382 | $22 |
| Trazodone | 14 | $371 | $27 |
| Sertraline | 36 | $351 | $10 |
| Sumatriptan | 21 | $319 | $15 |
| Meloxicam | 16 | $248 | $15 |
| Paroxetine | 11 | $244 | $22 |
| Tamsulosin | 16 | $240 | $15 |
| Lovastatin | 18 | $235 | $13 |
| Pravastatin | 15 | $225 | $15 |
| Furosemide | 30 | $192 | $6 |
| Metformin Hcl Er | 26 | $184 | $7 |
| Clotrimazole | 12 | $171 | $14 |
| Quetiapine | 13 | $170 | $13 |
| Benazepril | 11 | $163 | $15 |
| Hydrocodone-Acetaminophen | 17 | $161 | $9 |
| Zolpidem | 35 | $147 | $4 |
| Clonazepam | 19 | $146 | $8 |
| Fluticasone Propionate | 11 | $142 | $13 |
| Citalopram Hbr | 18 | $132 | $7 |
| Buspirone | 11 | $127 | $12 |
| Glipizide | 12 | $117 | $10 |
| Lisinopril-Hydrochlorothiazide | 11 | $112 | $10 |
| Finasteride | 11 | $111 | $10 |
| Lorazepam | 31 | $80 | $3 |
| Alprazolam | 14 | $61 | $4 |
| Cephalexin | 11 | $47 | $4 |
2021: 26 drugs
| Trelegy Ellipta | 13 | $8,291 | $638 |
| Atorvastatin | 100 | $1,449 | $14 |
| Losartan | 73 | $1,352 | $19 |
| Ventolin Hfa | 14 | $1,174 | $84 |
| Estradiol | 11 | $1,121 | $102 |
| Levothyroxine | 35 | $811 | $23 |
| Amlodipine Besylate | 87 | $709 | $8 |
| Pregabalin | 16 | $697 | $44 |
| Valsartan | 19 | $673 | $35 |
| Irbesartan | 11 | $651 | $59 |
| Mirtazapine | 11 | $555 | $50 |
| Gabapentin | 27 | $475 | $18 |
| Escitalopram | 11 | $348 | $32 |
| Hydrochlorothiazide | 37 | $305 | $8 |
| Rosuvastatin | 11 | $264 | $24 |
| Triamterene-Hydrochlorothiazid | 11 | $230 | $21 |
| Metformin | 25 | $203 | $8 |
| Potassium Chloride | 16 | $175 | $11 |
| Alendronate | 20 | $172 | $9 |
| Lisinopril | 18 | $145 | $8 |
| Omeprazole | 13 | $125 | $10 |
| Simvastatin | 19 | $112 | $6 |
| Zolpidem | 25 | $89 | $4 |
| Lorazepam | 19 | $69 | $4 |
| Hydrocodone-Acetaminophen | 12 | $69 | $6 |
| Clonazepam | 15 | $66 | $4 |
Professional record
- NPI
- 1215461645
- Licence
- CA A160368California A160368: Current · expires 2027-01-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2017-04-12
- NPI last updated
- 2026-03-09
- NPI record certified
- 2026-03-09
This is when the NPI record was last certified, not a medical board exam.